Spyre Therapeutics Inc (SYRE)

Operating Cash Flow Growth

-50.07%

Quarterly · Period ending:

SYRE logo

SYRE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-50.07%
SYRE Quarterly Cash from Operations YoY % (-85.16% → -50.07%)
High-resolution chart · PNG

SYRE operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-50.0698%
-39.9522%
-19.8366%
-26.1582%
25.1976%
-43.6269%
-19.8576%
14.9608%
-274.0191%
-61.8578%
-71.0915%
-129.6058%
19.494%
32.8561%
5.8543%
11.3647%
-1,092.9395%
-34.4752%
-12.4679%
3.0566%
110.7248%
9.9751%
-5.143%
-1.9061%
-18.4948%
-37.243%
-126.3056%
-102.3994%
-81.1477%
-112.26%
-22.5949%
-15.3909%
-52.2046%
-37.095%
-34.8565%
-25.6266%
-28.2815%
-36.2086%
-422.8091%
-53.8966%
-20.1556%
-60.6122%
72%
-111.4872%
-216.7625%
-85.1603%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.